Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.592
https://www.valueinhealthjournal.com/article/S1098-3015(16)31958-1/fulltext
Title :
Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31958-1&doi=10.1016/j.jval.2016.09.592
First page :
A449
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
559